网站主页 >> CAS数据库列表 >> 3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑
3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑
|
|
- CAS号:
- 271576-80-8
- 英文名:
- 3-[N-(2-Hydroxyacetyl)-4-piperidyl]-4-(4-pyrimidinyl)-5-(4-chlorophenyl)pyrazole
- 英文别名:
- SD-06;SD 0006;SD-06-1;CS-2591;SD 0006(SD-06);SD-06;SD 06;SD06;3-[N-(2-Hydroxyacetyl)-4-piperidyl]-4-(4-pyrimidinyl)-5-(4-chlorophenyl)pyrazole;1-(4-(5-(4-Chlorophenyl)-4-(pyrimidin-4-yl)-1H-pyrazol-3-yl)piperidin-1-yl)-2-hydroxyethanone;Ethanone, 1-[4-[5-(4-chlorophenyl)-4-(4-pyrimidinyl)-1H-pyrazol-3-yl]-1-piperidinyl]-2-hydroxy-;1-(4-(5-(4-chlorophenyl)-4-(pyrimidin-4-yl)-1H-pyrazol-3-yl)piperidin-1-yl)-2-hydroxyethan-1-one
- 中文名:
- 3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑
- 中文别名:
- ATG-010;SD-06-1游离;SD-06,P38Α MAPK 的二芳基吡唑抑制剂;3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑;3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑 1级;1-(4-(5-(4-氯苯基)-4-(嘧啶-4-基)-1H-吡唑-3-基)哌啶-1-基)-2-羟基乙酮
- CBNumber:
- CB62554318
- 分子式:
- C20H20ClN5O2
- 分子量:
- 397.86
- MOL File:
- 271576-80-8.mol
|
|
|
3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑化学性质
-
沸点:
-
652.6±55.0 °C(Predicted)
-
|
-
密度:
-
1.367
-
|
-
储存条件:
-
2-8°C
-
|
-
溶解度:
-
DMSO : 50 mg/mL (125.67 mM; Need ultrasonic)
-
|
-
形态:
-
Powder
-
|
-
酸度系数(pKa):
-
9.39±0.50(Predicted)
-
|
3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑性质、用途与生产工艺
SD 0006 (SD-06) 是口服有效的、选择性的、ATP竞争性的、有效的 p38α MAPK 的二芳基吡唑抑制剂,其IC50 值为 110 nM。
SD 0006 clearly inhibits p38α as shown by the dose-dependent inhibition of phosphorylation of its endogenous Hsp27 substrate.
SD 0006 (0-30 mg/kg) may be an effective alternative to steroids and biologics for RA therapy.
SD0006 (3.75, 7.5 and 15 mg/kg; p.o.; b.i.d.) is highly effective in attenuating SCW-induced inflammation as shown by the dose-dependent inhibition of paw swelling.
Animal Model:
|
8- to 12-week-old DBA/1 mice.
|
Dosage:
|
3.75, 7.5 and 15 mg/kg.
|
Administration:
|
Orally twice daily.
|
Result:
|
Inhibited the transcription of several inflammatory mediators to prevent joint swelling and bone destruction and to preserve bone density.
|
3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/04/30 | HY-11087 | SD 0006 | | 1 mg | 500元 |
2024/04/30 | HY-11087 | 3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑 SD 0006 | 271576-80-8 | 10mM * 1mLin DMSO | 1210元 |
3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑
生产厂家
271576-80-8, 3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑 相关搜索:
- MAPK
- 药靶配体
- SD-06,P38Α MAPK 的二芳基吡唑抑制剂
- SD-06-1游离
- 1-(4-(5-(4-氯苯基)-4-(嘧啶-4-基)-1H-吡唑-3-基)哌啶-1-基)-2-羟基乙酮
- 3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑 1级
- ATG-010
- 3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑
- 271576-80-8
- 1-(4-(5-(4-chlorophenyl)-4-(pyrimidin-4-yl)-1H-pyrazol-3-yl)piperidin-1-yl)-2-hydroxyethan-1-one
- Ethanone, 1-[4-[5-(4-chlorophenyl)-4-(4-pyrimidinyl)-1H-pyrazol-3-yl]-1-piperidinyl]-2-hydroxy-
- CS-2591
- SD 0006(SD-06)
- SD-06;SD 06;SD06
- SD 0006
- 1-(4-(5-(4-Chlorophenyl)-4-(pyrimidin-4-yl)-1H-pyrazol-3-yl)piperidin-1-yl)-2-hydroxyethanone
- SD-06-1
- SD-06
- 3-[N-(2-Hydroxyacetyl)-4-piperidyl]-4-(4-pyrimidinyl)-5-(4-chlorophenyl)pyrazole